A strong support for an oncogenic function of p32 is also provided by studies demonstrating that cancer cells generally express higher levels of p32 compared to their normal counterparts (Chen et al., 2009; Fogal et al., 2008; Rubinstein et al., 2004). This evidence concerns the gene C1QBP and cancer.